Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Duverger

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
European Journal of Biochemistry|October 15, 1991
Functional characterization of human recombinant apolipoprotein AIV produced in Escherichia coliN Duverger, A Murry-Brelier, M Latta, et al.
Nature Genetics|August 4, 1999
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1S Rust, M Rosier, H Funke, et al.
Circulation|August 15, 1996
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsN Duverger, H Kruth, F Emmanuel, et al.
Circulation|August 3, 1999
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient miceM Rouis, C Adamy, N Duverger, et al.
Human Gene Therapy|January 20, 1997
Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cellsG Liu, K J Excoffon, P Benoit, et al.
Protein Science : a Publication of the Protein Society|April 16, 1998
A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modelingF Peelman, N Vinaimont, A Verhee, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 30, 1999
Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol effluxU Daum, C Langer, N Duverger, et al.
Biochemistry|February 25, 1997
Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transportG Castro, L P Nihoul, C Dengremont, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Transgenic rabbits expressing human apolipoprotein A-I in the liverN Duverger, C Viglietta, L Berthou, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 4, 1998
Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transferG Liu, K J Excoffon, J E Wilson, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Biochemistry|October 15, 1991
Functional characterization of human recombinant apolipoprotein AIV produced in Escherichia coliN Duverger, A Murry-Brelier, M Latta, et al.
Nature Genetics|August 4, 1999
Tangier disease is caused by mutations in the gene encoding ATP-binding cassette transporter 1S Rust, M Rosier, H Funke, et al.
Circulation|August 15, 1996
Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbitsN Duverger, H Kruth, F Emmanuel, et al.
Circulation|August 3, 1999
Adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-1 reduces atherosclerotic lesions in apolipoprotein E-deficient miceM Rouis, C Adamy, N Duverger, et al.
Human Gene Therapy|January 20, 1997
Efficient adenovirus-mediated ectopic gene expression of human lipoprotein lipase in human hepatic (HepG2) cellsG Liu, K J Excoffon, P Benoit, et al.
Protein Science : a Publication of the Protein Society|April 16, 1998
A proposed architecture for lecithin cholesterol acyl transferase (LCAT): identification of the catalytic triad and molecular modelingF Peelman, N Vinaimont, A Verhee, et al.
Journal of Molecular Medicine (Berlin, Germany)|October 30, 1999
Apolipoprotein A-I (R151C)Paris is defective in activation of lecithin: cholesterol acyltransferase but not in initial lipid binding, formation of reconstituted lipoproteins, or promotion of cholesterol effluxU Daum, C Langer, N Duverger, et al.
Biochemistry|February 25, 1997
Cholesterol efflux, lecithin-cholesterol acyltransferase activity, and pre-beta particle formation by serum from human apolipoprotein A-I and apolipoprotein A-I/apolipoprotein A-II transgenic mice consistent with the latter being less effective for reverse cholesterol transportG Castro, L P Nihoul, C Dengremont, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 1, 1996
Transgenic rabbits expressing human apolipoprotein A-I in the liverN Duverger, C Viglietta, L Berthou, et al.
Clinical and Investigative Medicine. Medecine Clinique Et Experimentale|November 4, 1998
Enhanced lipolysis in normal mice expressing liver-derived human lipoprotein lipase after adenoviral gene transferG Liu, K J Excoffon, J E Wilson, et al.
Pageof 6